TEST - Book of PDFs-01_Loiselle Chest2016PulmNoduleScreentoDxLoiselle09092016 CMS.pptx

01_Loiselle Chest2016PulmNoduleScreentoDxLoiselle09092016 CMS.pptx - 1

Pdf Summary

This document discusses pulmonary nodules and their diagnosis, specifically focusing on lung cancer screening. The National Lung Screening Trial is mentioned, which was a prospective randomized trial conducted across 33 sites in the US. The trial included individuals aged 55-74 with a history of smoking and who were medically fit for treatment. The results showed that low-dose computed tomography (LDCT) had a 20% reduction in lung cancer mortality compared to chest X-ray. However, there was a high false positive rate in both groups, leading to unnecessary procedures and anxiety for patients. The number needed to screen varied across different risk groups. The document then compares the NLST population to the US population, noting differences in age, smoking status, and education. The USPSTF has given a grade B recommendation for lung cancer screening in individuals aged 55-80 with an eligible smoking history. A case study is also provided, discussing a 65-year-old male with a history of smoking and other medical conditions. The document concludes with a mention of the ACCP 2013 Guidelines for lung cancer screening, which may provide further recommendations for diagnosing and managing pulmonary nodules.

Keywords

pulmonary nodules

lung cancer screening

National Lung Screening Trial

low-dose computed tomography

chest X-ray

false positive rate

number needed to screen

US population

USPSTF

ACCP 2013 Guidelines